Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
GlaxoSmithKline ( (GB:GSK) ) has shared an update.
GSK plc has repurchased 690,000 of its ordinary shares on 6 March 2026 under its ongoing share buyback programme, using BNP Paribas as broker, at a volume‑weighted average price of 2,048.95 pence. The shares will be held in treasury, bringing total buybacks since 17 February to 7,156,000 shares, and leaving 4,069,121,728 shares in issue and 6.07% of voting rights now held in treasury.
The transaction, executed across London Stock Exchange and Cboe Europe venues, further concentrates GSK’s equity base and may enhance earnings per share for remaining investors. The updated voting-rights figure also provides a new reference point for shareholders’ disclosure obligations under U.K. transparency rules, underlining the governance and regulatory dimensions of the buyback activity.
The most recent analyst rating on (GB:GSK) stock is a Sell with a £19.00 price target. To see the full list of analyst forecasts on GlaxoSmithKline stock, see the GB:GSK Stock Forecast page.
Spark’s Take on GB:GSK Stock
According to Spark, TipRanks’ AI Analyst, GB:GSK is a Neutral.
The score is driven primarily by strong profitability and improving recent fundamentals, supported by constructive 2026 guidance and pipeline momentum. Valuation is reasonable with a modest yield, while the main constraint is technical overbought risk and ongoing balance-sheet/earnings-consistency considerations.
To see Spark’s full report on GB:GSK stock, click here.
More about GlaxoSmithKline
GSK plc is a global biopharmaceutical company focused on developing, manufacturing, and commercialising vaccines and specialty medicines. The group targets major therapeutic areas including infectious diseases, HIV, respiratory and oncology, and it is a constituent of the U.K. blue-chip equity indices with a broad international shareholder base.
Average Trading Volume: 9,000,906
Technical Sentiment Signal: Buy
Current Market Cap: £81.66B
For detailed information about GSK stock, go to TipRanks’ Stock Analysis page.